Percocet is one of the most widely prescribed opioid analgesics in the United States and, at the same time, one of the most closely regulated. It is a fixed-combination product containing oxycodone, a full opioid agonist, and acetaminophen, a non-opioid analgesic and antipyretic. The combination is designed to provide pain relief through two different mechanisms while limiting the dose of each individual component.
For patients with acute or severe pain for whom non-opioid treatments are inadequate, Percocet can provide meaningful relief. It is also a Schedule II controlled substance with a well-documented set of properties—respiratory depression, addiction potential, dependence, acetaminophen-related liver considerations, and extensive drug interactions—that make how it is prescribed and taken genuinely important.
This guide covers Percocet in full: what it is, its composition and formulations, its approved use, how it works, its effects, its legal classification, and what appropriate medical access and monitoring look like.
Percocet is a combination prescription medication. Each tablet contains two active ingredients in fixed proportions:
Oxycodone hydrochloride — a full opioid agonist that is relatively selective for the mu-opioid receptor
Acetaminophen — a non-opioid analgesic and antipyretic
Percocet tablets are available in several strengths, each containing 325 mg of acetaminophen combined with varying amounts of oxycodone:
2.5 mg/325 mg
5 mg/325 mg
7.5 mg/325 mg
10 mg/325 mg
The 325 mg acetaminophen strength is notable: earlier formulations contained higher acetaminophen doses (up to 500 mg per tablet), but the trend across the industry has been toward lower acetaminophen content per tablet to reduce the risk of accidental hepatotoxicity from cumulative daily intake.
The acetaminophen in Percocet is not merely a filler. It carries its own clinical considerations. The FDA labeling warns that large amounts of acetaminophen may cause liver damage if taken for a long time, and patients should carefully check the labels of all other medicines they are using because they may also contain acetaminophen. It is not safe to use more than 4,000 milligrams of acetaminophen in one day from all sources. Patients with liver disease may have a lower daily maximum dose.
Percocet has a specific and narrow approved indication.
Percocet is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate, when other pain treatments such as non-opioid pain medicines do not treat the pain well enough or the patient cannot tolerate them.
The labeling is explicit that opioid analgesics, including Percocet, should be reserved for use in patients for whom alternative treatment options—non-opioid analgesics or opioid combination products—are ineffective, not tolerated, or would otherwise be inadequate.
The labeling directs taking the prescribed dose every 6 hours as needed for pain. Patients should not take more than the prescribed dose. If a dose is missed, the next dose should be taken at the usual time.
Mild pain manageable with non-opioid analgesics
Long-term use without periodic reassessment of continued need
Use in patients with severe asthma, trouble breathing, or other lung problems — these are contraindications
Use in patients with bowel blockage or narrowing of the stomach or intestines — contraindicated
Use without a prescription—Percocet is a Schedule II controlled substance
The two components work through different mechanisms.
Oxycodone works by binding to opioid receptors in the central nervous system, primarily the mu-opioid receptor. The principal therapeutic action is analgesia. Like all full opioid agonists, there is no ceiling effect for analgesia—dosage is titrated to provide adequate analgesia and may be limited by adverse reactions, including respiratory and CNS depression.
Oxycodone produces respiratory depression by direct action on brain stem respiratory centers. The depression involves a reduction in the responsiveness of the brain stem respiratory centers to both increases in carbon dioxide tension and electrical stimulation.
The precise mechanism of acetaminophen's analgesic properties is not fully established but is thought to involve central actions. Unlike nonsteroidal anti-inflammatory drugs, acetaminophen does not have significant anti-inflammatory properties.
Percocet is an immediate-release formulation, typically dosed every 6 hours as needed. Oxycodone has an oral bioavailability of approximately 87% in cancer patients, and acetaminophen is rapidly and almost completely absorbed from the gastrointestinal tract.
This is the clinical core of what Percocet is, and it is not optional information.
Percocet carries a boxed warning for addiction, abuse, and misuse. The labeling states that even if the medication is taken correctly as prescribed, there is a risk for opioid addiction, abuse, and misuse that can lead to death.
Physical dependence is an expected consequence of prolonged opioid use. The labeling directs that patients be assessed for risk of abuse prior to prescribing and reassessed regularly for the development of these behaviors and conditions.
Tolerance is the need for increasing doses to maintain a defined effect such as analgesia. The minimum effective analgesic concentration of oxycodone may increase over time due to an increase in pain, the development of a new pain syndrome, and/or the development of analgesic tolerance.
The labeling warns: "If you have been taking PERCOCET regularly, do not stop taking PERCOCET without talking to your healthcare provider". Abrupt discontinuation after prolonged use can produce withdrawal symptoms. When discontinuing in a physically dependent patient, a gradual taper is directed.
Percocet carries a boxed warning for life-threatening respiratory depression. When first starting Percocet, when the dose is changed, or if too much is taken, serious or life-threatening breathing problems that can lead to death may occur.
A further boxed warning addresses combined use with benzodiazepines, alcohol, or other central nervous system depressants, including street drugs. This combination can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.
The labeling specifically advises patients not to drink alcohol or use prescription or over-the-counter medicines that contain alcohol during treatment with Percocet, as this may cause overdose and death.
Accidental ingestion of even one dose of Percocet, especially by children, can result in fatal overdose. The labeling directs storing Percocet securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home.
Percocet can make patients sleepy, dizzy, or lightheaded. The labeling directs not driving or operating heavy machinery until the patient knows how Percocet affects them.
The most commonly reported adverse reactions with Percocet are:
Constipation
Nausea
Sleepiness
Vomiting
Tiredness
Headache
Dizziness
Abdominal pain
Patients should call their healthcare provider if any of these symptoms are severe. Constipation is a predictable opioid effect and can be managed with stool softeners, laxatives, and adequate hydration.
Percocet's prescribing information contains multiple boxed warnings. These are the most serious warning category the FDA uses, and they reflect documented clinical events.
As described above, Percocet carries a boxed warning for addiction, abuse, and misuse, which can lead to overdose and death.
As described above, respiratory depression is the subject of a boxed warning. The risk is greatest when starting Percocet or when the dosage is increased, and it can occur even at recommended dosages.
Accidental ingestion, especially by children, may result in respiratory depression or death.
As described above, this combination can cause profound sedation, respiratory depression, coma, and death.
Prolonged use of Percocet during pregnancy can cause withdrawal symptoms in the newborn baby that could be life-threatening if not recognized and treated. The labeling directs that management by neonatology experts be available at delivery.
Large amounts of acetaminophen may cause liver damage if taken for a long time. Patients must carefully check all other medications for acetaminophen content and must not exceed the maximum daily dose.
Cases of adrenal insufficiency have been reported with opioid use, more often following greater than one month of use.
Cases of serotonin syndrome, a potentially life-threatening condition, have been reported during concomitant use of opioids with serotonergic drugs.
Anaphylaxis has been reported with ingredients contained in Percocet.
Cases of androgen deficiency have occurred with use of opioids for an extended period of time.
Cases of hyperalgesia and allodynia have been reported with opioid therapy of any duration.
Cases of hypoglycemia have been reported in patients taking opioids, most often in patients with at least one predisposing risk factor such as diabetes.
Percocet passes into breast milk and may harm the baby. Patients should carefully observe infants for increased sleepiness, breathing difficulties, or limpness, and seek immediate medical care if these signs appear.
Percocet interacts with a significant number of medications and substances. Anyone taking it should disclose all medications, supplements, and recreational substances to their prescriber and pharmacist.
Notable interactions include :
Benzodiazepines and other CNS depressants — Profound sedation and respiratory depression; the subject of a boxed warning.
Alcohol — Specifically warned against; compounds sedation and increases overdose risk.
CYP3A4 inhibitors — May increase oxycodone plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression.
CYP3A4 inducers — Discontinuation of a concomitantly used CYP3A4 inducer may result in an increase in oxycodone plasma concentration.
Serotonergic drugs — May result in serotonin syndrome.
Other acetaminophen-containing products — Risk of exceeding the maximum daily acetaminophen dose.
This is not an exhaustive list. A pharmacist consultation is advisable before starting any new medication while taking Percocet.
Pain is assessed through clinical evaluation—severity, duration, cause, impact on function, and response to prior treatments. The labeling directs that Percocet be prescribed only by healthcare professionals knowledgeable about the use of opioids and how to mitigate the associated risks.
Percocet is a Schedule II controlled substance under the federal Controlled Substances Act. This means it requires a prescription from a licensed prescriber with a valid DEA registration. Schedule II status means no refills are permitted; each fill requires a new prescription.
Prescriptions are dispensed by a licensed pharmacy. Pharmacists verify prescriptions and may check prescription drug monitoring programs to detect duplicate or excessive prescribing.
Prescribers are directed to assess each patient's risk for opioid addiction, abuse, or misuse prior to prescribing and to reassess patients regularly for the development of these behaviors and conditions. Monitoring typically includes:
Pain control and functional improvement
Signs of addiction, abuse, or misuse
Respiratory status and sedation
Total daily acetaminophen intake from all sources
Bowel function (constipation management)
Mood changes
The labeling directs storing Percocet securely, out of sight and reach of children, and in a location not accessible by others. Expired, unwanted, or unused Percocet should be disposed of by promptly flushing down the toilet if a drug take-back option is not readily available.
When Percocet is discontinued in a physically dependent patient, a gradual taper is directed. Abrupt discontinuation is associated with withdrawal symptoms.
Percocet is a combination prescription pain medication containing oxycodone (an opioid) and acetaminophen. It is used for pain severe enough to require an opioid when alternative treatments are inadequate.
Yes. Percocet is a Schedule II controlled substance, meaning it has a high potential for abuse and no refills are permitted.
Constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, and abdominal pain are among the most commonly reported effects.
No. The labeling directs that patients who have been taking Percocet regularly should not stop taking it without talking to their healthcare provider.
Combining Percocet with alcohol, benzodiazepines, or other CNS depressants can cause severe drowsiness, breathing problems, coma, and death. This is the subject of a boxed warning.
Percocet tablets contain 325 mg of acetaminophen per tablet. The total daily acetaminophen intake from all sources should not exceed 4,000 mg.
Seek emergency medical help or call 911 right away for trouble breathing, shortness of breath, fast heartbeat, chest pain, swelling of the face, tongue, or throat, extreme drowsiness, light-headedness when changing positions, feeling faint, agitation, high body temperature, trouble walking, stiff muscles, or mental changes such as confusion. Naloxone is an opioid overdose reversal agent; patients and caregivers should be advised about its use.
Percocet is an effective medication for severe pain when prescribed and monitored by a clinician. It is also a Schedule II opioid combination product with boxed warnings for addiction, abuse, misuse, life-threatening respiratory depression, accidental ingestion, and combined use with benzodiazepines and other CNS depressants. The acetaminophen component adds a liver consideration that requires attention to total daily intake from all sources.
Comments